financetom
Business
financetom
/
Business
/
EU withdraws marketing authorisation for Abbvie's hepatitis C drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU withdraws marketing authorisation for Abbvie's hepatitis C drug
Oct 2, 2024 10:23 PM

Oct 1 (Reuters) - The European Medicines Agency said on

Tuesday that it has withdrawn the marketing authorisation for

Abbvie's ( ABBV ) hepatitis C drug Exviera at the request of the

company.

The regulator said it withdrew authorisation for the drug on

Sept. 25.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved